Evidence map›Paper›PMID 39318837›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2024

A Multi-Specialty Delphi Consensus on Assessing and Managing Cardiopulmonary Risk in Patients with COPD.

Mohit Bhutani, Jean Bourbeau, Shaun G Goodman, Nathaniel Mark Hawkins, Alan G Kaplan, Peter James Lin, Erika Dianne Penz, Subodh Verma, Shelley Zieroth

Abstract readConsensus Statement
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mohit BhutaniDepartment of Medicine, Division of Pulmonary Medicine, University of Alberta, Edmonton, Alberta, Canada.
Jean BourbeauDepartment of Medicine, Division of Pulmonary Medicine, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
Shaun G GoodmanDepartment of Medicine, Division of Cardiology, University of Toronto, Toronto, Ontario, Canada.
Nathaniel Mark HawkinsDepartment of Medicine, Division of Cardiology, University of British Columbia, Vancouver, British Columbia.ORCID 0000-0003-1286-2014
Alan G KaplanDepartment of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0001-8795-5528
Peter James LinThe Canadian Heart Research Centre, Primary Care Initiatives, Toronto, Ontario, Canada.
Erika Dianne PenzCollege of Medicine, Division of Respirology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Subodh VermaDepartment of Surgery, Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
Shelley ZierothCollege of Medicine, Section of Cardiology, University of Manitoba, Winnipeg, Manitoba, Canada.

Funding

AstraZeneca Canada Ltd. (AstraZeneca)
6 · The paper itself

Abstract

Background: In Canada, COPD represents a significant burden to the patient and health system, as it is often under or misdiagnosed and sub-optimally treated. Cardiovascular disease (CVD) is a common co-morbidity in COPD and there is significant interplay between these two chronic conditions. Across all stages of COPD disease severity, deaths can be attributed not only to respiratory causes but also to cardiovascular-related factors. The established links between COPD and CVD suggest the need for a greater degree of collaboration between respirologists and cardiologists. This modified Delphi consensus was initiated to consider how optimal COPD care can be delivered within Canada, with specific consideration of reducing cardiopulmonary risk and outcomes in COPD patients. Methods: A steering group with interest in the management of COPD and CVD from primary care, cardiology, and respirology identified 40 statements formed from four key themes. A 4-point Likert scale questionnaire was sent to healthcare professionals working in COPD across Canada by an independent third party to assess agreement (consensus) with these statements. Consensus was defined as high if ≥75% and very high if ≥90% of respondents agreed with a statement. Results: A total of 100 responses were received from respirologists (n=30), cardiologists (n=30), and primary care physicians (n=40). Consensus was very strong (≥90%) in 28 (70%) statements, strong (≥75 and <90%) in 7 (17.5%) statements and was not achieved (<75%) in 5 (12.5%) of statements. Conclusion: Based on the consensus scores, 9 key recommendations were proposed by the steering group. These focus on the need to comprehensively risk stratify and manage COPD patients to help prevent exacerbations. Consensus within this study provides a call to action for the expeditious implementation of the latest COPD guidelines from the Canadian Thoracic Society.

Indexed as

Cardiovascular DiseasesDelphi TechniquePulmonary Disease, Chronic ObstructiveCanadaCardiologistsComorbidityCooperative BehaviorHeart Disease Risk FactorsHumansInterdisciplinary CommunicationLungPatient Care TeamPredictive Value of TestsPrognosisPulmonary MedicinePulmonologistsCanadachronic obstructive pulmonary diseaseconsensus developmentconsultation and referralhealth careprimary care

Identifiers

PMID39318837
PMCPMC11420896

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.